Leukemia For Twins and Stem Cells Solutions
Posted on July 6, 2008
Although there are no accurate data for concordance rates of leukemia in infant twins, anecdotally it seems to be exceptionally high, perhaps approaching one hundred percent that is, if one twin has it, unfortunately so will the other. If correct, this suggests that MLL gene fusion in utero has a dramatic impact, ensuring subsequent leukemia. But for children aged two to six years with acute lymphoblastic leukemia, the concordance rate is considerably lower at around five percent. This still represents a one hundred fold extra risk of leukemia for the twin of a patient with acute lymphoblastic leukemia but also indicates the need for some additional postnatal event for which there is a one in twenty chance, or ninety five percent discordance. This suggests, at a minimum, a “two hit” model for the natural course of childhood leukemia.
If this model of leukemia development is correct, then, for every child with acute lymphoblastic leukemia diagnosed, there should be at least twenty healthy children who have had a chromosome translocation, a functional leukemia fusion gene, and a covert preleukaemic clone generated in utero. This possibility has been investigated by screening unselected samples of newborn cord blood for fusion genes. About six hundred samples have been screened, and around one percent have a leukemia TEL瑼ML1 fusion gene. This one percent represents a hundred times the cumulative rate or risk of acute lymphoblastic leukemia, indicating that the frequency of conversion of the preleukaemic clone to overt disease is low. The real bottleneck in development of acute lymphoblastic leukemia therefore seems to be a stringent requirement for a second “hit” after birth-that is, exposure and additional chromosomal or molecular abnormality.
A key issue to resolve is what exposures or events might precipitate the chromosome breaks whose improper repair initiates or promotes childhood leukemia. Given the biological diversity of leukemia, it is highly unlikely that there is a single cause. Even for a defined biological subtype of the disease, there probably is not one cause as such but a causal mechanism. As with other cancers, this is likely to involve an interaction of exposure, exogenous or endogenous, with inherent genetic susceptibility, and chance. Epidemiological evidence suggests that ionizing radiation; certain chemicals such as benzene, viruses, and bacteria may play a part in the development of some subtypes of leukemia and lymphoma in adults and children.
Whether any of these exposures have a major role in childhood leukemia is uncertain, but large scale case control molecular epidemiological studies in Britain and the United States may provide answers. The United Kingdom children’s cancer study (UKCCS) seeks to address several hypotheses on different exposures, combined with definition of biological subtypes of disease and genetic studies. It and a parallel US study have already ruled out electromagnetic fields as a major factor in leukemia aetiology.
Having stem cells extracted from the cord blood at birth and stored in a cord blood bank or a stem cells bank is a way to protect your child from future diseases.
It can be very useful as it contains hematopoietic stem cells, progenitor cells. The stem cells in the cord blood are mainly used to treat blood and immune system related genetic diseases, cancers and blood disorders like diabetes or leukemia.
Wayne Channon, Director of Cells4Life Ltd, a Stem cell and cord blood storage expert.
Stem cell and cord blood storage
Article Author :Wayne_Channon
Last 6 posts in Leukemia Lymphoma Cancer
- Structure and Function of Blood and Bone Marrow - August 25th, 2008
- What Are Leukemias? - August 8th, 2008
- Prevent Leukemia Lymphoma Cancer - August 8th, 2008
- A Client, Not a Patient - August 8th, 2008
- Childhood Leukemia and the Help of Stem Cells - August 8th, 2008
- Chronic Leukemia Surgery - Manage it in India - August 8th, 2008
- Prevent - Leukemia Lymphoma Cancer - July 23rd, 2008
- What is Non-Hodgkins Lymphoma? - July 6th, 2008
- Blood Cancer - Causes and Treatment - June 10th, 2008
- Non-Hodgkins Lymphoma, Marriage, and Children - It Was Meant To Be - April 7th, 2008
Pain is an unpleasant sensation. Most mesothelioma patients suffer from pain to a certain degree. It can be mild but it can also be acute or chronic. Acute pain is severe pain that comes quickly but usually lasts for a short time. On the other hand chronic pain is more persistent and lasts for a longer period of time. Pain arises both from the tumor itself and from the treatment taken. Chemotherapy, radiation and surgery can cause pain. Perhaps it is chemotherapy drugs that cause the most discomforts.
Chemotherapy usually cause discomforts as much or sometimes even more than pain caused… Continue reading
Perhaps one of the most visible symptoms that an individual has cancer is hair loss. Many patients are very aware and concerned about the loss of their hair. Hair thinning and hair loss is a common side effect of some chemotherapy drugs and radiation therapy. This occurs because chemotherapy drugs damages rapid growing cells such as those of mesothelioma but also other normal rapid growing cells such as that of the hair. However the hair will grow some time after chemotherapy is terminated and it may not necessary be of the same texture or color as was prior to chemotherapy.
There… Continue reading
Chemotherapy drugs can have a temporal effect on the bone marrow and may so cause a reduction in the red blood cells, white blood cells and platelets. If there is a reduction of these cells, the body is easily bruised and bleeding will take longer to stop. White blood cells fight infections and so by a drop in the count of these cells, the body will be less able to fight any infection. Symptoms as headaches, muscle pain, sore throat, a cough, feeling cold and problems in passing urine may be an indication of an infection. It is very important… Continue reading
Related posts
» Filed Under Leukemia Lymphoma Cancer
Comments
Leave a Reply